Dicerna Pharmaceuticals Inc (DRNA) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dicerna Pharmaceuticals Inc   (NASDAQ: DRNA)


Dicerna Pharmaceuticals Inc's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dicerna Pharmaceuticals Inc's ROI in the third quarter of 2021?
Dicerna Pharmaceuticals Inc recorded a cumulative net loss of $-124 million during 12 months ending in the third quarter of 2021, resulting in a negative return on investment (ROI) of -22.68%.

Within the Healthcare sector 341 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2021 from 0 to 3664.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM 22.09 % 33.8 % 42.65 % 71.86 % 81.14 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 533 631 501 530 442
Return On Investment (TTM) -22.68 % -24.57 % -24.7 % -22.87 % -25.77 %
DRNA's Overall Ranking # 3664 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 4.32 % 8.08 % -1.28 % 9.69 % 14.31 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -124 -129 -120 -113 -116

DRNA Company Profile >> Back to DRNA Roi Comparisons >> See Annual DRNA Return On Investment



Return On Investment DRNA's Ranking
Within: No.
Industry # 110
Sector # 342
Overall # 3664

Return On Investment Statistics
High Average Low
-15.09 %
-57.32 %
-123.19 %
(Sep 30 2021)   (Mar 31 2017)







Financial Statements
Dicerna Pharmaceuticals Inc's III. Quarter Investments $ 533 Millions DRNA's Balance sheet
Dicerna Pharmaceuticals Inc's III. Quarter Income $ -17 Millions Quarterly DRNA's Income Statement
DRNA's Income by Division See DRNA's Income by Division


DRNA Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 530 356 201 104 41
Y / Y Investment Growth 48.99 % 77.22 % 92.53 % 152.96 % -54.73 %
Net Income in Millions -113 -120 -89 -64 -60
Y / Y Net Income Growth - - - - -
Annual Return On Investment -21.28 % -33.87 % -44.27 % -61.29 % -144.42 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DRNA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DRNA's Competitors
Subscribers only: Roi for Dicerna Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for DRNA's Customers

Other Ratios
DRNA's Roa DRNA's Inventory Turnover Ratio DRNA's Growth Rates DRNA's Dividend Statistics
DRNA's Profitability Ratios DRNA's Asset Turnover Ratio DRNA's Dividend Growth
DRNA's Roe DRNA's Valuation Ratios DRNA's Financial Strength Ratios DRNA's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI

Date modified: 2026-09-26T07:08:33+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.